Brighter partners with Indonesia Mampu to fight diabetes in Indonesia.

Brighter has signed an agreement for contributing to the development of the first healthcare initiative within Indonesia Mampu, a program of works led by Palladium and the Indonesian government body National Team Secretariat for Accelerating Poverty Reduction (TNP2K). Indonesia Mampu’s partnership framework is aimed at alleviating poverty in Indonesia through a positive impact program based on four pillars of which one is healthcare. As part of this pillar there will be a focus on diabetes prevention and treatment where Brighter’s knowledge and technology will be an important component.

A vital part of the Indonesia Mampu approach is the participation of the private sector, and therefore the program selects the best suitable partners within different sectors for its diabetes prevention and treatment initiative; including food & nutrition, tech & data and pharma & health where Brighter with its Actiste® is sorted under as the only diabetes management tool.

“Palladium & TNP2K are excited to welcome Brighter to the Cegah Risiko Tinggi Partnership Indonesia Mampu’s first initiative in the healthcare space. Brighter brings extensive experience in creating innovative solutions for health management and integrated data systems regarding diabetes management, which is key to improve the diabetes landscape in Indonesia. Statistics show that diabetes prevalence among Indonesia’s youth is higher than average; with a projected growth to become the world’s fourth largest. We look forward to working together to tackle this issue and deliver positive impact in Indonesia," says Armando Cubillan, Director of Positive Impact Partnerships, Palladium Indonesia.

The program aims to map and identify the true number of people living with diabetes in a multi-step approach. The Cegah Risiko Tinggi Partnership within Indonesia Mampu will unite government agencies, policy makers, professionals in diabetes treatment, private sector and donors to create awareness of diabetes, develop promotive-preventive initiatives, and facilitate treatment with the goal of reducing the growth rate of the disease in Indonesia. The result is expected, among other things, to generate an increase of access to state of the art diabetes treatment and management. The partnership will help Brighter to penetrate Indonesia’s market by enhancing its current efforts with Indosat Ooredoo and Ericsson.

“Brighter is committed to provide access to diabetes management and innovative solutions for patients across Indonesia, and this partnership will help us to strengthen and materialise that commitment,” says Truls Sjöstedt, CEO and founder of Brighter.

Within the partnership Brighter will:

  • Enable remote monitoring and follow-up using the Actiste Diabetes Management as a Service.
  • Train personnel to be able to train users in all available channels on how to manage their condition with help of Actiste.
  • Enable direct real time upload of data from Actiste on to a centralised database.
  • Enable real time shared KPIs through its system that can measure and analyse Big Data and impact to determine best interventions.

For more information, please contact:
Truls Sjöstedt, CEO       
Tel: +46 709 73 46 00       

Henrik Norström, COO       
Tel: +46 733 40 30 45       

About Palladium Group.
Palladium is a global leader in the development and delivery of Positive Impact - the point where commercial, social and environmental goals are inextricably linked and where the impact on each are equally considered. We work with governments, corporations, and non-profits to deliver solutions that transform lives and create enduring value for businesses, communities, societies and economies. For the past 50 years, we’ve been making positive impact possible. With a team of more than 2,000 employees and experience working in 120 countries, Palladium is committed to improving people’s lives, societies and economies.

About Brighter AB.
Brighter develops solutions for data-driven and mobile health services. Through its intellectual property and its first launch Actiste®, the company creates a more efficient care chain with focus on the individual. The goal is to simplify, streamline and enhance the information flow of relevant and reliable data between the patient and health care professionals. Brighter is initially focused on diabetes care and care for the elderly, but there are opportunities in the future to operate on a broader level, spanning more diseases and treatment approaches. This is done through The Benefit Loop®, Brighter’s cloud-based service that continuously collects, analyzes and shares data on the user's terms.

The Company's shares are listed on NASDAQOMX FIRST NORTH/BRIG. Brighter's Certified Adviser is Remium Nordic AB, +46 (0)8 454 32 50,

This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 08:30 CET on April 4, 2017.


About Us

Brighter is a Swedish-based company that, from a unique IP portfolio, creates smart solutions for one of the most serious healthcare problems: changing patient behavior. Chronic diseases such as diabetes are rapidly increasing and account for an increasing share of healthcare costs globally. Brighter's Business Model and Multi-Sided Market Platform - The Benefit Loop™ - is based on the fact that many special interests create value for each other. By increasing access to valid health data, Brighter creates value for all stakeholders in the care chain: patients and close associates, healthcare providers, research, pharmaceutical industry and society. The Company's shares are listed on NASDAQOMX First North/BRIG. Brighter’s Certified Adviser on Nasdaq OMX First North is Remium Nordic Holding AB +46 (0)8 – 454 32 50,,


Documents & Links